Raymon Pharma

Raymon Pharma was founded in March 2018 and is located in the Biomedical Industry Park of Suzhou Industrial Park. It is a company that focuses on the ophthalmic drug field and is committed to the development of small molecule innovative ophthalmic drugs. The company has multiple sustainable innovative pipelines, with products involving various targets and mechanisms of action. Dr. Zhang Fei, the founder, graduated from Columbia University in the United States and has held key positions in new drug research and development at Merck and Novartis, accumulating nearly 20 years of experience in new drug R&D. The company boasts a professional core team with members from world-renowned pharmaceutical companies such as Novartis and Alcon, each averaging over 30 years of experience in new drug development, and having led the launch and out-licensing of multiple drugs. Raymon Pharma possesses a globally leading medicinal chemistry design platform in the field of drug penetration and treatment for eye diseases, particularly those affecting the fundus.